Population Substructure and Control Selection in Genome-Wide Association Studies by Yu, Kai et al.
 
Population Substructure and Control Selection in Genome-Wide
Association Studies
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Yu, Kai, Zhaoming Wang, Qizhai Li, Sholom Wacholder, David J.
Hunter, Robert N. Hoover, Stephen Chanock, and Gilles Thomas.
2008. Population substructure and control selection in genome-
wide association studies. PLoS ONE 3(7): e2551.
Published Version doi:10.1371/journal.pone.0002551
Accessed February 19, 2015 7:33:35 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10198687
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAPopulation Substructure and Control Selection in
Genome-Wide Association Studies
Kai Yu
1*, Zhaoming Wang
1,2, Qizhai Li
1,3, Sholom Wacholder
1, David J. Hunter
1,4, Robert N. Hoover
1,
Stephen Chanock
1, Gilles Thomas
1
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America, 2Core Genotyping Facility, Advanced
Technology Program, SAIC Frederick, Inc. National Cancer Institute - Frederick, Frederick, Maryland, United States of America, 3Academy of Mathematics and Systems
Science, Chinese Academy of Sciences (CAS), Beijing, China, 4Program in Molecular and Genetic Epidemiology, Department of Epidemiology, Harvard School of Public
Health, Boston, Massachusetts, United States of America
Abstract
Determination of the relevance of both demanding classical epidemiologic criteria for control selection and robust handling
of population stratification (PS) represents a major challenge in the design and analysis of genome-wide association studies
(GWAS). Empirical data from two GWAS in European Americans of the Cancer Genetic Markers of Susceptibility (CGEMS)
project were used to evaluate the impact of PS in studies with different control selection strategies. In each of the two
original case-control studies nested in corresponding prospective cohorts, a minor confounding effect due to PS (inflation
factor l of 1.025 and 1.005) was observed. In contrast, when the control groups were exchanged to mimic a cost-effective
but theoretically less desirable control selection strategy, the confounding effects were larger (l of 1.090 and 1.062). A panel
of 12,898 autosomal SNPs common to both the Illumina and Affymetrix commercial platforms and with low local
background linkage disequilibrium (pair-wise r
2,0.004) was selected to infer population substructure with principal
component analysis. A novel permutation procedure was developed for the correction of PS that identified a smaller set of
principal components and achieved a better control of type I error (to l of 1.032 and 1.006, respectively) than currently used
methods. The overlap between sets of SNPs in the bottom 5% of p-values based on the new test and the test without PS
correction was about 80%, with the majority of discordant SNPs having both ranks close to the threshold. Thus, for the
CGEMS GWAS of prostate and breast cancer conducted in European Americans, PS does not appear to be a major problem
in well-designed studies. A study using suboptimal controls can have acceptable type I error when an effective strategy for
the correction of PS is employed.
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Introduction
Genome-wide association studies (GWAS) have emerged as an
effective approach to identify common polymorphisms underlying
complex traits [1–4]. In place of a family-based design frequently
employed in linkage scans, GWAS use a case-control design
primarily because of its efficiency in investigating a large number
of common variants in the genome together with the availability of
sufficiently large collections of unrelated cases with or without
coordinated collections of controls.
The presence of population stratification (PS)—allele frequency
differences between cases and controls due to systematic ancestry
differences—can lead to greater than nominal type I error rate [5–
11]. Differences in the origin of populations of cases and controls
can arise if the two groups are recruited independently or have
different inclusion criteria. Differences in ancestry between cases
and controls can also occur even if cases and controls are drawn
from the same heterogeneous population, such as the European
American population, when the disease risk varies across
subpopulations due to differences in distribution of unmeasured
risk factors [5]. Although the potential for an increase in false
positives in well-designed association studies conducted in a
stratified population is indisputable [6,7,12], the extent and impact
of PS on case-control association studies in practice, particularly in
GWAS, can now be thoroughly investigated as empirical evidence
from recent association studies becomes available.
One principle of classical epidemiologic study design is that the
distribution of risk factors of interest in controls should be the same
as the distribution in the population from which cases have been
ascertained [13]. A population-based study satisfies this principle
by choosing a random sample of controls from the same
population from which cases are selected. Violation of this
principle in the studies of genetic effects may be of less concern
than in the studies of environmental risk factors, if the distribution
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2551of population ancestry in individual cases and controls is available
and can be used to control the type I error rate at the cost of only a
modest drop in power. Principal component analysis [14–17] or
other methods [18,19] can be used to estimate the population
ancestry from the genotypes on a panel of SNPs not associated
with the disease status. The SNP panel can be selected from the
large number of SNPs typed in GWAS, of which the vast majority
(.99%) are not expected to be related to the disease under study.
Furthermore, a second set of SNPs, minimally correlated with the
previous one chosen for ancestry inference can be used to evaluate
the extent of confounding by PS as well as the effectiveness of the
correction for PS, by comparing the distribution of the test statistic
(with or without the correction for PS) observed over the second
set of SNPs with its expected distribution under the null
hypothesis. Systematic inflation in the observed statistics would
indicate that ancestry effects have not been fully controlled. Thus,
we postulate that the analysis of thousands of well-chosen SNPs
distributed throughout the genome could permit relaxation of the
requirement that cases and controls share the same population of
origin. In this regard, it is possible to analyze cases and controls
recruited from independently designed studies or allow the use of a
single, common control group for a variety of disease groups, a
strategy successfully used by the Welcome Trust Case Control
Consortium (WTCCC) to identify novel variants in a number of
common diseases [20].
The Cancer Genetic Markers of Susceptibility (CGEMS)
project has conducted two multi-stage GWAS in breast cancer
and prostate cancer [1,3,21]. For each disease, the initial genome-
wide scan was performed in a nested case-control study drawn
from a prospective cohort in self-described European Americans.
The CGEMS data provides the opportunity for empirical
evaluation of the impact of population stratification in an optimal
study design. By exchanging the control groups of the two studies,
we have explored the consequences of the non-standard strategy of
using external controls. We thus can make comparisons between
the two approaches.
We identified a set of autosomal SNPs common to both the
Illumina and Affymetrix commercial platforms that can robustly
monitor residual population structure in European American
populations. One commonly used approach for the correction of
PS is to adjust simultaneously for a fixed number of top-ranked
principal components (PCs) resulting from a principal component
analysis [15,16]. However, this approach may have an overly
negative impact on the power if the cases and controls are equally
distributed along the selected PCs, or if the adjustment of certain
covariates (such as self identified ethnicity, or recruitment center)
already included in the association analyses correctly maps to
major axes of genetic heterogeneity. To efficiently identify the
relevant PCs and keep their number to a minimum while allowing
an effective correction, we have developed a permutation
procedure to evaluate their effectiveness on PS correction as
additional PCs are taken for adjustment in the association test.
Taken together, these developments provide a procedure that
should be helpful for both PS evaluation and adjustment in
GWAS.
Materials and Methods
Study material
Both the genome-wide scans used in this study analyzed
approximately 550,000 SNPs on the Illumina platform. The
prostate cancer study genotyped cases and matched controls
collected from the Prostate, Lung, Colorectal and Ovarian
(PLCO) Cancer Screening Trial using the HumanHap300
(Illumina, San Diego, CA) and HumanHap240 chips (Illumina,
San Diego, CA) [1]. The breast cancer scan used the
HumanHap550 chip (Illumina, San Diego, CA), which is
equivalent to the HumanHap300 and HumanHap240 chips
combined, to genotype cases and their matched controls collected
from the Nurses’ Health Study (NHS) cohort [2]. In both studies,
participants were restricted to individuals who were of self-
described European descent. Quality control and quality assess-
ment removed subjects with low completion rates (,90%),
subjects with evidence of an intercontinental admixture (European
admixture coefficient less than 90%, estimated by STRUCTURE
[19]), and removal of one of each pair of first-degree relatives
(identified using PREST [22]). No second degree relatives were
detected. For this study, the test set for the PLCO prostate cancer
study consisted of 1,171 prostate cancer cases and 1,094 controls
while the test set for the NHS breast cancer study included 1,140
breast cancer cases and 1,138 controls. Four combinations of cases
and controls were analyzed: PLCO cases vs. PLCO controls
(PLCOca-PLCOco), NHS cases vs. NHS controls (NHSca-
NHSco), PLCO cases vs. NHS controls (PLCOca-NHSco), and
NHS cases vs. PLCO controls (NHSca-PLCOco).
Further data cleaning of the autosomal SNPs typed in both
PLCO and NHS scans retained SNPs with MAF .5%, a P-value
for fitness for Hardy-Weinberg proportion equilibrium exact test
.10
25 in both control sets, and a rate of missing genotypes ,5%.
A handful of SNPs that had different genotype frequencies
between the PLCO controls and NHS controls (with P-value
,10
27 based on the 2-df chi-squared test) were removed, most
likely due to informatic inconsistencies in SNP identification
between studies. In total, 475,116 autosomal SNPs (hereafter
called the testing SNPs) were identified for further analysis.
Algorithm to select a set of SNPs for population structure
inference
To optimize the principal components analysis of population
structure, we identified a set of SNPs with low background LD,
i.e., r
2 LD statistic [23] less than a given threshold r2
0 (e.g., 0.004)
within a given physical distance d (e.g., 500 kb). Our algorithm
modifies the greedy search algorithm of Carlson et al. [24], which
selects the minimum number of SNPs (called tagSNPs) necessary
to monitor remaining non-tagSNP above a threshold level of
correlation (measured by r
2). For our purposes, the SNP selection
algorithm differs in that it identifies the maximum number of
mutually ‘‘independent’’ SNPs for the inference of population
structure.
The algorithm selected a panel of population structure inference
SNPs by iterating over the following three steps. First, for each
SNP (called the reference SNP in this process) in the selection pool,
all SNPs that are within the distance d of the reference SNP and
have the r
2 LD measure with the reference SNP above the
threshold r2
0 were identified and grouped as a bin. Second, the bin
with the smallest size is identified, with its reference SNP being
added to the list of structure inference SNPs. If more than two bins
have the minimal size, we randomly pick one. Third, the selection
pool of SNPs is updated by removing every SNP included in the
bin identified in the second step. The process is complete when no
SNP is left in the selection pool.
The above algorithm can be used with no prior information
concerning population structure but when prior information on
the population structure, such as ethnic background, is available, it
may be of interest to identify a smaller set of highly informative
SNPs. In this case, the criteria suggested by Pfaff et al [25] can be
used in the bin selection applied in step 2. Also the algorithm can
Population Structure in GWAS
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of structure inference SNPs from an augmented pool of SNPs.
Statistical analysis
Here we provide more details on main statistical methods used
in the analyses.
Principal component analysis. We chose a panel of M
structure inference SNPs for the detection and correction of
population substructure in a GWAS with a total of N cases and
controls. The genotype at a marker locus is coded as 0, 1 or 2,
corresponding to the copy number of an arbitrary allele. Let gi,m be
the genotype measured at SNP m for the ith subject, 1#i#N,
1#m#M. The PCA summarizes the information measured on M
structure inference SNPs and represents study participants by their
projected positions (called principal components, or PCs) along a
few orthogonal axes with ‘‘large’’ genetic variations.
There are various forms of PCA for genetic data depending on
how the covariance matrix is calculated. Here we follow the
EIGENSTRAT method [15,16]. We first standardize each
genotype coding as ^ gi,m~
gi,m{2fm ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
fm 1{fm ðÞ
p , with fm~ 1
2N
P N
l~1
gl,m being
the allele frequency for the m
th marker. In the following discussion,
we always use the standardized genotype and still represent it as
gi,m, and organize all genotypes into the matrix G=(gi,m)N6M.W e
obtain the sample covariance matrix
P
~ 1
N G
0G for the M
markers. For the PCA, we find the first L (say L=3) largest
eigenvalues of S, and their corresponding normalized eigenvec-
tors, v1, v2,… ,vL, with vl=(vl,1,vl,2,…,vl,M)9,1 #l#L. For the ith
subject with genotypes (standardized as above) gi=(gi,1,gi,2,…,gi,M)9,
its lth principal component (PC) is given by ul,i~g0
ivl,1 #l#L.
Thus, vl defines the PC direction with the lth largest ‘‘genetic’’
variation and ul,i is the ith subject’s projected position onto this axis.
Following Patterson et al., the significance level of the genetic
variation along a given PC direction is evaluated by the Tracy-
Widom test [16].
In the eigenvector vl=(vl,1,vl,2,…,vl,M)9, its mth element vl,m,
called loading, 1#m#M, reflects the influence of mth marker on
shaping vl. Following suggestions from the WTCCC, the loading
of every SNP on the vl can be used to search for chromosomal
regions where variation pattern among samples would determine
the lth PC direction. A PC that reflects regional genetic variation
will be evidenced by a spike of high loadings for markers in that
chromosomal region.
Measuring the correlation between two PC directions. If
two groups of subjects (e.g., PLCOca-PLCOco and NHSca-
NHSco) are collected from the same population, we expect the
significant PC directions from both groups to point in similar
directions. We can quantify the similarity of two directions using
the Spearman rank correlation coefficient of the loading of every
SNP along these directions.
Between-groups comparison along a PC direction. The
confounding effect of PS only occurs when systematic
population structure differences exist between cases and
controls. Once one or more PC directions with large genetic
variation are identified through PCA, comparison of PCs for
cases along that axis with those of controls using the Wilcoxon
rank sum test can be informative. This is a non-parametric test
for evaluating whether two sets of observations have comparable
distribution.
Selection of PC for PS correction. An approach commonly
used to correct for PS is to adjust simultaneously for a fixed
number of top- ranked PCs or for those PCs that have significantly
large genetic variation according to the Tracy-Widom test [15,16].
This approach might not be optimal if selected PCs are distributed
almost equally in cases and controls [26]. In Text S1, we have
presented an illustrative example of how unnecessary adjustment
of population substructure (even one PC) could lead to a
significant loss in power (Text S1, Table S1).
Our selection procedure attempts to include only PCs that are
useful for the correction of PS. A PC is chosen whenever its
inclusion can significantly reduce the inflation in type I error rate,
measured by the over-dispersion factor, in comparison with the
addition of a randomly generated covariate. Once a set of PCs has
been identified, they are adjusted with other covariates in a
standard logistic regression model.
To apply this procedure, it is necessary to determine a set of
markers for which the inflation in type I error for the chosen test
statistic (with or without PC adjustment) can be properly
measured. Ideally, to avoid bias, this set of markers should be
uncorrelated with the set of markers used for PC detection, and
not associated with the disease risk. To such an end, we can
identify a large set S (approximately 240,000 SNPs) of genomic
control markers that do not exceed a threshold level of LD with
any SNPs used in the PCA. Although several disease-related SNPs
might be included in this set, their effect on the inflation estimation
can be ignored as the vast majority of the SNPs in the set S would
not be disease-related. For each genomic control SNP in S,
assuming an additive genetic model, a 1-df Wald test can be
performed by adjusting any chosen PCs and other covariates.
Following Devlin and Roeder [27], the over-dispersion factor can
be estimated as the median of Wald test statistics over the set of
genomic control SNPs divided by the expected median of the
chosen test statistics under the null hypothesis (i.e., in the present
case 0.456). The intent in our study is to use the over-dispersion
factor for the purpose of evaluating the effectiveness in the
correction of PS by adjusting for a given set of PCs, but not for the
adjustment for association testing results as originally proposed by
others [27,28]. The over-dispersion factor provides a summary
measure for the inflation level in the type I error. Although, as we
show below, the over-dispersion factor tends to be positively
correlated with empirical type I errors under various considered
significant levels, there is no simple analytic relationship between
them. For example, in our analysis of NHSca-PLCOco described
later, the over-dispersion factor at the level of 1.06 corresponds to
14%, 20% and 30% inflation in type I error under the significant
level of 0.05, 0.01 and 0.001, respectively.
To limit the searching space, we focus on only PCs with
significantly large genetic variation (with P-values less than 0.05
based on the Tracy-Widom test). The number of significant PCs,
represented by L, is either 4 or 5 among the four considered scans (the
two original and the two reconstructed). Let ul=(ul,,1,ul,2,…,ul,N)9,
1#l#L be the vector of the lth PCs for all subjects. To reduce the
computing time further, we order those L PCs u1, u2,… ,uL
according to their Wilcoxon rank-sum test statistics that compare the
distributions between cases and controls along individual PCs, and
define them in that order as u(1), u(2),… ,u(L),w i t hu(1) being the PC
withthelargestWilcoxon rank-sumteststatistic.Weusethefollowing
greedy search algorithm to choose a subset of PCs for the correction
of PS by sequentially evaluating u(1), u(2),… ,u(L).
1. Define E to be the set of selected PCs, starting with E=w, the
empty set.
2. Iterate the following two steps for l=1toL.
a. Use a permutation procedure (described below) to
evaluate the empirical P-value associated with the
‘impact’’ of adjusting for the PC u(l) in addition to
those already in E.
Population Structure in GWAS
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(say, 0.05), expand the set E by adding u(l), otherwise,
leave the set E unchanged
3. The set E at the end of L iterations is the final set of PCs to be
adjusted in the association test.
The permutation procedure used in step 2.a is designed to
determine if adjusting for the PC u(l) in addition to those already
included in E results into a significantly lower over-dispersion
factor, compared with the level expected under the situation when
the additional covariate to be adjusted for is randomly generated,
and thus has no contribution to the correction of PS. The rationale
is that we should adjust for u(l) whenever its inclusion makes a
‘‘significant’’ impact on the correction of PS. Here are the basic
steps for the permutation procedure used in the lth iteration of the
search algorithm.
i. Obtain the ‘‘observed’’ over-dispersion factor ^ l by
applying the test with adjustment for the PC u(l) as well
as those already included in E on SNPs from the set S.
ii. Randomly permute entries in the vector u(l) a predeter-
mined number of times, B, and denote the resulting
permuted version of u(l) as u
b ðÞ
l ðÞ, b=1,…,B.
iii. Based on u
b ðÞ
l ðÞ, b=1,…,B, obtain the over-dispersion
factor l
(b) by applying the test with adjustment for u
(b) as
well as those included in E on SNPs within the set S.
iv. The empirical P-value associated with the PC u
(b) is
estimated as the proportion of l
(b), b=1,…,B, that are
smaller than the ‘‘observed’’ ^ l.
In the above permutation procedure, each l
(b) is the over-
dispersion factor based on the test adjusting for covariates included
in E as well as u
b ðÞ
l ðÞ, which is a the permuted version of u(l). All l
(b),
b=1,…,B, provide the reference distribution for the evaluation of
^ l. We find in our numerical experiments that the median of l
(b),
b=1,…,B, is roughly at the same level as lCurrent, the over-
dispersion factor for the test adjusting for only covariates included
in E. Thus, if the additional adjustment of u(l) (in addition to the
ones already in E) does not lead to an over-dispersion factor ^ l l that
is lower than the current level (lCurrent), we skip the permutation
procedure and do not choose u(l).
In our analyses, we used 100 permutation steps and approx-
imately 240,000 genomic control SNPs for the evaluation of the
over-dispersion factor in each permutation step. Thus, the
permutation procedure may be computationally intensive. If
necessary, the computing time may be shortened by selecting
SNPs that are unrelated (i.e., low background LD).
Implementation. The algorithm for the selection of
structural inference SNPs was implemented in the Python
programming language. All the other analyses were conducted
using the open-source R language.
Results
The set of structure inference SNPs
To assemble a set of common SNPs informative for inference of
population substructure (called structure inference SNPs) for
GWAS, initially we identified a set of 40,817 autosomal SNPs
common to Affymetrix 500 k, Illumnia HumanHap300 and
Illumina HumanHap550, filtered on the basis of a completion
rate greater than 95% in both CGEMS scans, minor allele
frequency (MAF) .5%, and a fitness for Hardy-Weinberg
proportion exact test P-value .10
23 in both control sets. From
this pool of SNPs, using our described selection algorithm we
selected 12,898 structure inference SNPs that had low background
LD in the joint PLCO and NHS control samples (r
2 less than 0.004
for any pair located within 500 kb on the same chromosome). The
detailed list is provided in the Table S2, together with a visual
representation of the position and observed MAF of the SNPs on
the chromosomes (Figure S1).
The set of structure inference SNPs was used in the PCA to
detect axes with large genetic variations for the two original
genome wide scans and the two test studies in which controls were
swapped between PLCO and NHS. Inspection of the SNP
loadings plotted along each chromosome indicated that none of
the top 5 PCs from each of 4 studies showed evidence of being
driven by regional genetic variation pattern (see example of Figure
S2).
Using a slightly modified version of the SNP selection algorithm
described in the Material and Methods Section, from the list of
475,116 testing SNPs monitored by the Illumina HumanHap550
chip, we identified a new second set of 7,017 structure inference
SNPs that are locally uncorrelated (r
2 less than 0.004 for any pair
located less than 500 kb apart on the same chromosome) among
themselves and similarly uncorrelated to the 12,898 SNPs already
identified. The dependence of the PCA conclusions on the set of
structure inference SNPs can be evaluated by comparing the
results using the first set of 12,898 SNPs to those obtained with the
second set of 7,017 SNPs
The set of genomic control SNPs for the assessment of
over-dispersion
For association tests without PC adjustment, an unbiased
evaluation of the over-dispersion factor l can be obtained using all
the 475,116 testing autosomal SNPs. For evaluation after PC
adjustment, it is however important to avoid the potential bias that
can arise from SNPs highly correlated to the initial structure
inference SNP set. Thus, l is better estimated based on testing
statistics measured on a set of genomic control SNPs with no
correlation with the set of structure inference SNPs. To remain
consistent throughout the analyses, the over-dispersion factor l for
tests with or without PC adjustment was systematically evaluated
with the same set of 241,238 genomic control (autosomal) SNPs
having r
2 less than 0.01 with any nearby (within a distance of
500 kb) structure inference SNP from either the 12,898 or the
7,017 SNP sets. See Figure 1 for a summary of the relationship
among the three sets of SNPs.
Population structure in the PLCO prostate cancer study
We applied the PCA using the set of 12,898 structure inference
SNPs in the original nested case-control study of prostate cancer
(PLCOca-PLCOco) and found that the top 4 PCs are strongly
significant with P-values less than 10
24 based on the Tracy Widom
test, while the 5
th is borderline significant (Table 1). To further
justify the existence of axes with large genetic variation, we
conducted a new PCA on PLCOca-PLCOcn using the alternative
7,017 structure inference SNPs described above (Table S3). In this
case, the first two PCs were highly significant, namely a Tracy-
Widom test P-value ,10
27, but the additional lower ranked PCs
(third and onwards) had P-value larger than 0.05. It is notable that
there is a significant correlation for the first, as well as the second
PC between the two PCAs (with Spearman rank correlation
coefficient larger than 0.5 and P-value less than 10
215). Since the
lower ranked (third and onwards) PCs estimated by the smaller set
of SNPs were not significant, their correlations with the ones
estimated by the larger set of SNPs were not evaluated.
Population Structure in GWAS
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cases and controls
An analysis of the 12,898 structure inference SNPs in the
original breast cancer study (NHSca-NHSco) as well as the two
reconstructed studies using external controls (PLCOca-NHSco
and NHSca-PLCOco) demonstrated that there were at least 3 PC
directions with highly significant large genetic variations (Table 1).
The PCA with the second set of 7,017 structure inference SNPs
indicates that there are three major PCs (Tracy-Widom test P-
value ,0.05) in NHSca-NHSco and NHSca-PLCO but only two
major PCs in PLCOca-NHSco (Table S3). The estimated PCs
along each major direction (the first three for NHSca-NHSco and
NHSca-PLCOco, the first two for PLCOca-NHSco) are highly
correlated with the counterparts estimated by the set of 12,898
SNPs (Spearman rank correlation coefficient .0.26 and P-value
,10
215).
Population structure comparison between PLCO prostate
cancer and NHS breast cancer studies
To compare the population substructure between the original
two CGEMS initial scans, the PLCOca-PLCOco and NHSca-
NHSco, we identified the PC directions by applying the PCA on
each study separately, and compared directions between two
studies using the Spearman rank correlation coefficient of the SNP
loadings (Table 2). The top three PC directions between the two
studies are significantly correlated (with Spearman rank correla-
tion coefficient .0.14, and P-value ,10
215).
We performed a PCA on the joint sample including subjects
from both studies. A representation of each subject by its first 2
PCs in a scatter plot stratified by the study (PLCO or NHS) is
shown (Figure 2). Visual inspection of Figure 2A and 2B indicates
that patterns of population structure of the two studies are indeed
similar in the plane of the first 2 PCs. However, further scrutiny
reveals very significant difference between the two studies.
Between-studies comparisons using the Wilcoxon rank-sum test
suggest that the subjects from the two studies have significantly
Figure 1. A diagram for the three main sets of SNPs used in the text. The first set of PCA SNPs is used to identify hidden population
substructure. The set of genomic control SNPs is used to evaluate the over-dispersion factor in a given study, as well as in the proposed permutation
procedure to select relevant PCs for the correction of PS. The second set of PCA SNPs is used to validate findings from the first set of PCA SNPs. In
applications, only the first set of PCA SNPs is recommended.
doi:10.1371/journal.pone.0002551.g001
Table 1. Tracy-Widom tests and associated P-values (in
parenthesis) for the significance of principal components.
PLCOca-
PLCOco
a
PLCOca-
NHSco
b
NHSca-
NHSco
c
NHSca-
PLCOco
d
PC #1 514.40 (,10
27) 572.44 (,10
27) 771.37 (,10
27) 722.58 (,10
27)
PC #2 179.90 (,10
27) 211.20 (,10
27) 160.31 (,10
27) 142.95 (,10
27)
PC #39 . 9 0 ( ,10
27) 9.63 (,10
27) 35.38 (,10
27) 27.69 (,10
27)
PC #4 4.52 (7.0610
25) 1.05 (0.045) 9.66 (,10
27) 3.54 (5.8610
24)
PC #5 1.02 (0.047) 20.34 (0.238) 20.16 (0.168) 2.07 (9.2610
23)
Note: The tests are based on the principal components analyses with 12,898
population structure inference SNPs.
aPLCOca-PLCOco is the original PLCO prostate cancer study.
bPLCOca-NHSco is the reconstructed study with prostate cancer cases from the
PLCO, and external controls from NHS.
cNHSca-NHSco is the original NHS breast cancer study.
dNHSca-PLCOco is the reconstructed study with breast cancer cases from the
NHS, and external controls from PLCO.
doi:10.1371/journal.pone.0002551.t001
Population Structure in GWAS
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24) along each of the top
4 PC directions.
In summary, the comparable patterns in population substruc-
ture for the two genome-wide scans in PLCO and NHS suggest
that controls from one study may reliably be used to contrast with
cases from the other study in an association analysis. This
similarity is remarkable since the PLCO prostate cancer study was
assembled from male volunteers of European origin participating
in a cancer screen trial and enrolled at 10 screening centers while
the NHS breast cancer study was based on a sample of female
registered nurses participating in a long-term epidemiology study
originally enrolled from 14 large US states. However, because we
have also shown that the two studies have demonstrable genetic
background differences, using external controls in association
studies requires a careful examination of the confounding effect
due to PS. The observed genetic background difference between
the two studies could in part be due to the difference in geographic
locations of the source populations which were sampled, as people
from distinct regions tend to have different genetic background.
For example, by using the Kruskal-Wallis test [29], which is the
non-parametric version of the ANOVA test, we find that several
major PCs in each study have significantly different distributions
across different geographic locations (defined by either the
recruitment center in the PLCO prostate cancer study, or the
state of residence in the NHS breast cancer study).
Evidence of confounding by PS
Although we see evidence of at least three axes with large
genetic variations in each of the four combinations of cases and
controls considered here, confounding by PS would occur only
when cases and controls distribute differently along one or more
main axes of variations. To assess confounding by PS in each
study, we compared the distribution of the cases and controls for
each of the top 5 PC directions by using the Wilcoxon rank-sum
test (Table 3). The analysis was restricted to the first 5 PC
directions in each study since all other directions were not
significant by the Tracy-Widom test.
Table 2. Spearman rank correlation coefficients between
pairs of principal component directions from the original
PLCO prostate cancer and NHS breast cancer studies.
NHS
PC #1
NHS
PC #2
NHS
PC #3
NHS
PC #4
NHS
PC #5
PLCO PC #1 0.73 0.05 0.01 0.00 0.00
PLCO PC #2 0.04 0.51 0.03 0.02 0.00
PLCO PC #3 0.01 0.03 0.14 0.06 0.00
PLCO PC #4 0.02 0.00 0.10 0.05 0.03
PLCO PC #5 0.00 0.00 0.00 0.00 0.00
doi:10.1371/journal.pone.0002551.t002
Figure 2. Samples represented by their first two principal components. Principal components (PC, the 1
st along the horizontal direction, the
2
nd along the vertical direction)) were obtained by applying the PCA on the joint sample of PLCO prostate cancer and NHS breast cancer studies. A)
First two PCs for subjects from the PLCO prostate cancer study. B) First two PCs for subjects from the NHS breast cancer study.
doi:10.1371/journal.pone.0002551.g002
Table 3. Principal component comparisons (P-values)
between cases and controls based on the Wilcoxon rank-sum
test.
PLCOca-
PLCOco
a
PLCOca-
NHSco
b
NHSca-
NHSco
c
NHSca-
PLCOco
d
PC #1 0.294 4.5610
28 0.664 4.3610
26
PC #2 0.871 2.2610
27 0.289 6.9610
212
PC #3 0.340 0.282 0.036 4.0610
23
PC #4 0.588 1.2610
24 0.015 0.191
PC #5 0.490 0.385 0.943 0.157
Note: For each case-control combination, the Wilcoxon rank-sum tests are
based on principal components estimated with 12,898 population structure
inference SNPs.
aPLCOca-PLCOco is the original PLCO prostate cancer study.
bPLCOca-NHSco is the reconstructed study with prostate cancer cases from the
PLCO, and external controls from NHS.
cNHSca-NHSco is the original NHS breast cancer study.
dNHSca-PLCOco is the reconstructed study with breast cancer cases from the
NHS, and external controls from PLCO.
doi:10.1371/journal.pone.0002551.t003
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NHSco, no significant difference (after multiple comparison
adjustments) was observed between cases and controls with respect
to the distribution on each of the top 5 PC directions (Table 3).
Thus, a strong confounding effect by PS in either study is not to be
expected, even though PC directions with significantly large
genetic variation are evident in these studies. For the two
reconstructed studies with external controls, i.e., PLCOca-NHSco
and NHSca-PLCOco, cases and external controls display
significantly different distributions along the first two PC
directions. There is also a third direction (the 4
th PC direction in
PLCOca-NHSco, and the 3
rd PC direction in NHSca-PLCOco)
along which cases and external controls differ, although to a lesser
extent. Thus, compared with the two studies with internal controls,
these findings suggest that the confounding effects by PS are
accentuated when controls are culled from an independent study.
Confounding by PS could lead to an inflated type I error rate
for the association test. For each of the four combinations of cases
and controls, assuming an additive genetic model we performed a
1-df Wald test (without adjusting for PS) using the standard logistic
regression for each testing autosomal SNP. Table 4 shows the
over-dispersion factor and empirical type I error (assuming the
vast majority of testing SNPs are disease unrelated) under various
significance levels. All estimates presented in Table 4 are based on
tests performed with the same set of 241,238 genomic control
SNPs. They are close to estimates obtained when all 475,116
testing SNPs were used (results not shown). As expected, the two
reconstructed studies with external controls have larger over-
dispersion factors and higher empirical type I errors compared
with the original studies with internal controls. Similar conclusion
can be reached based on the Q-Q plot (on the log scale)
comparison in Figure 3. From Table 4, the over-dispersion factor
is positively correlated with empirical type I errors under various
considered significant levels. The over-dispersion factor is indeed a
good summary indicating the level of inflation in type I error, as
well as the extent of confounding effect. This justifies the use of
over-dispersion factor in the permutation procedure.
PC adjustment and its impact on over-dispersion factor
Following Price et al. [15], the confounding effect of PS can be
corrected by adjusting for a defined set of PCs. The typical method
adjusts for L top-ranked PCs, with L being either pre-determined
(e.g., 10), or the number of significant PCs (e.g., those with P-value
,0.05 based on the Tracy-Widom test). To evaluate this strategy,
we estimated over-dispersion factors for association tests (1 d.f.
Wald test) based on results on the set of 241,238 genomic control
SNPs with adjustment for varying numbers (from 1 to 10) of top
ranked PCs (Table 5). We observe that the over-dispersion factor
does not necessarily decrease as the number of adjusted PCs
increases. Table 5 also suggests that adjusting non-significant PCs
does not appear to have a major impact on the inflation reduction
The following simulation further supports this observation. For
each of the four considered studies, we rearranged each subject’s
case/control status so that new designated case and control groups
were completely separately on a chosen PC direction (e.g., the first
PC direction), and evaluated the over-dispersion factor and
empirical type I error rate in the new generated dataset. Results
are summarized in Table S4). When the mismatch (to the most
extreme extend) between cases and controls occurred on a PC with
large genetic variation, the resultant inflation in type I error was
much more severe than the one observed when the disparity
occurred on a PC with relatively low variation (high Tracy-Widom
test P-value). For all 4 considered studies, the over-dispersion
factor was around or less than 1.05 when the mismatch (in the
worst scenario) of cases and controls occurred on a PC with the
associated Tracy-Widom test P-value larger than 0.05.
Using 0.05 as the P-value threshold for selecting PCs with large
variation, four or five PCs were chosen for the four studies under
investigation (Table 1). Moreover, results from Table 5 suggest that
adjustment of a PC with significantly large variation may not
necessarily reduce the over-dispersion factor if cases and controls
have comparable distribution over that PC. For example, in the
original prostate cancer scan, the cases and controls have very similar
genetic background as seen in the 2
nd PC direction (see Table 5). In
this case, compared to adjustment of the first PC, adding the 2
nd PC
into the adjustment does not reduce the over-dispersion factor.
To minimize the number of adjusted PCs while allowing an
effective correction of the confounding effect by PS, our proposed
selection procedure identifies PCs that are effective in the reduction
of the over-dispersion factor.A PC is chosen for the correctionof PS
whenever the over-dispersion factor in the model with the PC
included is significantly lower than the expected value of the factor
from including an additional randomly generated covariate. When
applied to the two original studies, this new procedure identified a
single PC to achieve the optimal PS correction. Interestingly, the
procedure selected the first PC (corresponding to the largest genetic
variation) for the PLCO prostate cancer study, but the second PC
fortheNHSbreastcancerstudysuggestingthatthecontrolselection
procedure used in the NHS study effectively removed the
confounding that might have been caused by the axis with the
largest genetic variation. When the controls were exchanged
between the two studies, the procedure required the 1
st,2
nd,a n d
4
th PCs in PLCOca-NHSco, and the 1
st,2
nd,a n d3
rd PCs in
NHSca-PLCOco. Thus, the increased heterogeneity between cases
and controls created in the two reconstructed studies resulted in the
inclusionoftwoadditionalPCsinordertosufficientlycorrect forthe
confounding effect.
Compared to the strategy of adjusting for PCs with large genetic
variation, the proposed permutation procedure picks fewer PCs and
reduces the over-dispersion factor to a similar or even lower level
(Table 5). With either strategy, the over-dispersion factor is slightly
decreased from its uncorrected level in the two original studies with
Table 4. Over-dispersion factors and empirical type I errors
for the association test without the correction of PS.
Significance level
Study Over-dispersion 0.05
e 0.01
e 0.001
e
NHSca-NHSco
a 1.005 0.0505 0.0100 0.0010
PLCOca-PLCOco
b 1.025 0.0527 0.0110 0.0012
NHSca-PLCOco
c 1.062 0.0572 0.0120 0.0013
PLCOca-NHSco
d 1.090 0.0588 0.0127 0.0016
Note: The over-dispersion factor and empirical type I errors under various
significant levels are estimated by applying the 1-df Wald test statistic without
the correction of PS on the set of 241,238 genomic control SNPs. We assume all
genomic control SNPs are disease unrelated.
aNHSca-NHSco is the original NHS breast cancer study.
bPLCOca-PLCOco is the original PLCO prostate cancer study.
cNHSca-PLCOco is the reconstructed study with breast cancer cases from the
NHS, and external controls from PLCO.
dPLCOca-NHSco is the reconstructed study with prostate cancer cases from the
PLCO, and external controls from NHS.
eEmpirical type I error rates under the given significant level (assuming all
genomic control SNPs are disease-unrelated).
doi:10.1371/journal.pone.0002551.t004
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dispersionlevelcanbereducedsubstantiallyand animprovedfitting
of the Q-Q plot to the diagonal can be achieved. Comparison of
Figures 3 with 4 demonstrates the conspicuous effect of PC
adjustment in the two reconstructed analyses as this effect is hardly
visible on the two original studies with internal controls.
The impact of PC adjustment on SNP ranking and
selection for follow-up study
In a multiple-stage association study [30], the number of SNPs
to be taken into the follow-up steps is usually fixed in advance by
cost considerations so that the SNPs are selected based on the
ranking of their test statistics rather than their P-values. In
CGEMS, the number of SNPs to be taken in follow-up 1 was
approximately 5% of those used in the initial genome wide scan
[21]. Consequently, adjusting for PCs in the association test would
be expected to change the ranking of the SNPs. In Figures 5, 6 and
7 we show the rank shuffling among the set of 475,116 testing
SNPs in the prostate cancer study with internal controls (PLCOca-
PLCOco) and with external controls (PLCOca-NHSco). In either
case, PCs were selected by the proposed permutation procedure. A
similar pattern can be observed in the breast cancer studies with
Figure 3. Q-Q plot based on the test without PC adjustment. For each of the four analyses, the Q-Q plot is based on P-values (in log10 scale)
that correspond to the 1 d.f. Wald test on 475,116 testing autosomal SNPs by assuming an additive risk model (in logit scale) and without PC
adjustment. A) Results for the original prostate cancer study (prostate cancer cases and controls from PLCO). B) Result for the reconstructed prostate
cancer study using external controls (prostate cancer cases from PLCO, and external controls from NHS). C) Results for the original breast cancer study
(breast cancer cases and controls from NHS). D) Results for the reconstructed breast cancer study using external controls (breast cancer cases from
NHS, and external controls from PLCO).
doi:10.1371/journal.pone.0002551.g003
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Comparing Figure 5A with 5B shows the high correlation of the
two sets of ranks in the original study with internal controls and the
lower correlation in the reconstructed studies using external
controls. Figures 6 and 7 show the histogram of ranks according to
the test without PC adjustment for SNPs ranked within a given
range by the test with PC adjustment. Again, the discordance
between two ranks in the analyses with external controls is more
prominent than in the original study.
On the premise that the top 5% of the testing SNPs ranked by
the statistic using a given PC adjustment strategy are to be
followed-up to the next stage, we evaluated the concordance
between two sets of follow-up SNPs, namely, those chosen by the
test adjusting for PCs selected by the permutation procedure, and
those chosen by the test adjusting for PCs selected by an
alternative strategy (such as adjusting for the top 10 PCs, or no
PC adjustment). In PLCOca-PLCOco, among the follow-up SNPs
chosen by test without PC adjustment, approximately 7% of them
would not have been chosen by the test with the adjustment of PCs
identified by the permutation procedure. The discrepancy
increases to 23% in the corresponding study with external controls
PLCOca-NHSco (Table 6). A similar pattern was also observed in
the breast cancer studies with swapping of internal and external
controls. We note that in each of the four studies considered the
vast majority of SNPs ranked in the top 1% by the test with PC
adjustment were ranked within the top 5% by the test without PC
adjustment (Figures 6A, 7A, S5A, and S6A). Figures 5 and S3
show that both ranks of the most discordant SNPs are close to the
threshold.
Compared to the proposed permutation procedure, strategies
that would have taken the top 10 PCs or only the significant PCs
(P-value ,0.05 based on the Tracy-Widom test) would have
changed the selection of the follow-up SNPs by an average of 6.7%
or by an average of 4.6% among the four considered studies
(Table 6).
Numbers of SNPs needed for the PCA in GWAS
To empirically evaluate the relationship between the reduction
in the over-dispersion factor and the number of structure inference
SNPs used in the correction of PS, we focused on the
reconstructed study PLCOca-NHSco, where the most extensive
confounding by PS was observed (l=1.090). We conducted PCA
using nested sets of 1,500, 3,000, 6,000, 9,000 and 12,898
population structure inference SNPs (Table 7).
Table 7 shows that, as expected, using a larger number of SNPs
in the correction of PS results in the detection of more subtle
population structure. For example, with 12,898 SNPs, we can
detect four significant PCs (P-value ,0.05 based on the Tracy-
Widom test). With 6,000 or fewer population structure inference
SNPs, only two significant PCs can be identified. Also, the over-
dispersion factor of the test with the adjustment of PCs chosen by
the proposed permutation procedure decreases as the number of
SNPs used in the PCA increases. When 12,898 SNPs are used in
the correction of PS, we can reduce the over-dispersion factor to
an acceptable level (l=1.032) with the adjustment of 3 PCs.
The importance of choosing SNPs with low background
LD for PCA
The set of structural inference SNPs we chose for the PCA
consists of 12,898 SNPs that had low background LD measured in
the joint PLCO and NHS control samples (r
2 less than 0.004 for
any pair located within 500 kb on the same chromosome). The
restriction to SNPs with very low local pairwise correlation ensures
that the PCA findings reflect the genome-wide variation pattern,
and are not overly influenced by regional LD pattern. WTCCC
also adopted this strategy [20].
To demonstrate the importance of the selection of SNPs with
low background LD, we conducted PCA on the study PLCOca-
NHSco using all 12,536 autosomal SNPs located on chromosome
20 without filtering out SNPs in high LD, and summarized the
results in Table S5 and Figure S6. By inspecting the SNP loadings
Table 5. Over-dispersion factor (and the empirical type I error under the significant level of 0.05) for association tests with
adjustment for various numbers of PCs.
PCs chosen for the adjustment PLOCca-PLCOco
a PLCOca-NHSco
b NHSca-NHSco
c NHSca-PLCOco
d
0 PC 1.025 (0.053) 1.090 (0.059) 1.005 (0.051) 1.062 (0.057)
1
st PC 1.020 (0.052) 1.055 (0.055) 1.006 (0.050) 1.040 (0.055)
1–2 PCs 1.022 (0.052) 1.040 (0.053) 1.004 (0.050) 1.013 (0.052)
1–3 PCs 1.021 (0.052) 1.040 (0.053) 1.005 (0.050) 1.006 (0.052)
1–4 PCs 1.021 (0.052) 1.032 (0.053) 1.005 (0.050) 1.007 (0.052)
1–5 PCs 1.023 (0.052) 1.032 (0.053) 1.006 (0.050) 1.008 (0.052)
1–6 PCs 1.024 (0.052) 1.032 (0.053) 1.007 (0.050) 1.010 (0.052)
1–7 PCs 1.025 (0.052) 1.033 (0.053) 1.008 (0.050) 1.010 (0.051)
1–8 PCs 1.025 (0.052) 1.036 (0.053) 1.007 (0.051) 1.011 (0.052)
1–9 PCs 1.025 (0.053) 1.036 (0.053) 1.007 (0.051) 1.011 (0.052)
1–10 PCs 1.025 (0.053) 1.036 (0.053) 1.008 (0.051) 1.010 (0.052)
Selected PCs
e 1.020 (0.052) 1.032 (0.053) 1.003 (0.050) 1.006 (0.052)
Note: The over-dispersion factor (and the empirical type I error under the significant level of 0.05) are estimated by applying the 1-df Wald test statistic with the
adjustment for selected PCs on the set of 241,238 genomic control SNPs.
aPLCOca-PLCOco is the original PLCO prostate cancer study.
bPLCOca-NHSco is the reconstructed study with prostate cancer cases from the PLCO, and external controls from NHS.
cNHSca-NHSco is the original NHS breast cancer study.
dNHSca-PLCOco is the reconstructed study with breast cancer cases from the NHS, and external controls from PLCO.
eThose PCs were chosen by the proposed permutation procedure for the correction of PS. The selected sets of PCs for individual analyses (from left to right) are: 1
st PC;
1
st,2
nd,a n d4
th PCs; 2
nd PC; and 1
st,2
nd,a n d3
rd PCs. The PCs were ordered according to their corresponding eigenvalues
doi:10.1371/journal.pone.0002551.t005
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directions is heavily driven by regional LD patterns (Figure S6).
Thus, it is not surprising to see from Table S5 that the over-
dispersion is still high even after the adjustment of the top 10 PCs,
in contrast to the results shown in Table 5.
Discussion
We used empirical data from two GWAS within the CGEMS
project to assess the extent and impact of PS in studies with two
distinct control selection strategies. We also evaluated our
proposed procedures for choosing structural inference SNPs as
well as for selecting the PCs for correction of PS. In the two
original GWAS based on the nested case-control design, we
observed only minor confounding effect by PS with over-
dispersion factors of 1.025 and 1.005 for prostate and breast
cancer studies, respectively. These small inflations, which in
practice may not raise major concern, can be further reduced by
adjustment for a single PC. In the two reconstructed studies where
cases and controls were collected independently using different
Figure 4. Q-Q plot based on the test with PC adjustment. For each of the four analyses, the Q-Q plot is based on P-values (in log10 scale) that
correspond to the 1 d.f. Wald test on 475,116 testing autosomal SNPs by assuming an additive risk model (in logit scale) and with PC adjustment. The
PCs used in adjustment are selected by the proposed permutation procedure. A) Results for the original prostate cancer study (prostate cancer cases
and controls from PLCO). B) Results for the reconstructed prostate cancer study using external controls (prostate cancer cases from PLCO, and
external controls from NHS). C) Results for the original breast cancer study (breast cancer cases and controls from NHS). D) Results for the
reconstructed breast cancer study using external controls (breast cancer cases from NHS, and external controls from PLCO).
doi:10.1371/journal.pone.0002551.g004
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with over-dispersion factors of 1.090 and 1.062. In these studies
with external controls, three principal components were required
to optimally correct for the confounding effect of PS, resulting in
the reduction of the inflation factor to a level comparable to that in
the original nested case-control studies. Our conclusions are based
on two actual studies of two cancer sites and two hypothetical ones
Figure 5. SNP ranking correlation in prostate cancer studies. In each plot, SNPs’ rankings based on the 1 d.f. Wald test on 475,116 testing
autosomal SNPs without PC adjustment are compared with their rankings based on the 1 d.f. Wald test with adjustment for PCs chosen by the
permutation procedure. The SNPs in blue are ranked among the top 5% by tests both with and without PC adjustment. The SNPs in green and
orange are ranked among the top 5% by only one of the tests. A) Results based on the original prostate cancer study (prostate cancer cases and
controls from PLCO). The 1
st PC was chosen for PS correction. B) Results based on the reconstructed prostate cancer study using external controls
(prostate cancer cases from PLCO, and external controls from NHS). The 1
st,2
nd and 4
th PCs were chosen for PS correction.
doi:10.1371/journal.pone.0002551.g005
Figure 6. The conditional ranking distribution for the original
PLCO prostate cancer study. Each plot shows the histogram of
ranks according to the test without PC adjustment for SNPs ranked
within a given range by the test with the adjustment for the 1
st PC
(chosen by the proposed permutation procedure). The ranking ranges
(%) are shown on the horizontal axis. The frequencies (%) are shown on
the vertical axis. A) The histogram of ranks for SNPs ranked in the top 0–
1% by the test with PC adjustment. B) The histogram of ranks for SNPs
ranked in the top 1–2% by the test with PC adjustment. C) The
histogram of ranks for SNPs ranked in the top 2–3% by the test with PC
adjustment. D) The histogram of ranks for SNPs ranked in the top 3–4%
by the test with PC adjustment. E) The histogram of ranks for SNPs
ranked in the top 4–5% by the test with PC adjustment.
doi:10.1371/journal.pone.0002551.g006
Figure 7. The conditional ranking distribution for the recon-
structed prostate cancer study using external controls. Each
plot shows the histogram of ranks according to the test without PC
adjustment for SNPs ranked within a given range by the test with the
adjustment for the 1
st,2
nd, and 4
th PCs (chosen by the proposed
permutation procedure). The ranking ranges (%) are shown on the
horizontal axis. The frequencies (%) are shown on the vertical axis. A)
The histogram of ranks for SNPs ranked in the top 0–1% by the test with
PC adjustment. B) The histogram of ranks for SNPs ranked in the top 1–
2% by the test with PC adjustment. C) The histogram of ranks for SNPs
ranked in the top 2–3% by the test with PC adjustment. D) The
histogram of ranks for SNPs ranked in the top 3–4% by the test with PC
adjustment. E) The histogram of ranks for SNPs ranked in the top 4–5%
by the test with PC adjustment.
doi:10.1371/journal.pone.0002551.g007
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impact of PS in other populations, such as African Americans,
may be different and thus, requires independent assessment.
Case-control studies nested in prospective cohorts, such as the
two original GWAS in the CGEMS project, tend to minimize
biases introduced when cases and controls are selected from
different populations. We found that cases and controls had
comparable genetic background and only minor confounding
effect by PS in these two studies. In stand-alone case-control
studies, which are not nested within a cohort, the bias is likely to be
somewhat greater because of difficulties in control selection when
there is no roster of the underlying population producing the cases.
A more extreme but convenient and cost-efficient design
alternative, notably taken recently by the WTCCC [20], is the
use of external controls that are collected independently with little
reference to the population from which cases are selected. The
large number of disease-unrelated SNPs measured in a GWAS can
be utilized to evaluate and when applicable, correct for the
confounding effect induced by the genetic ancestral disparity
between the case and control groups. Therefore, the stringent
requirement of control selection imposed according to the classical
epidemiology paradigm could be relaxed to some extent. This
view is supported by our analyses of two reconstructed studies with
independently collected controls. It appears that an appropriate
PC adjustment can effectively correct for the elevated confounding
effect introduced by the use of less desirable controls.
Adjusting for unnecessary covariates incurs the risk of
decreasing power [31]. We have presented a simulation to
demonstrate that the unnecessary adjustment of population
substructure (even one PC) could lead to a significant loss in
power (Text S1, Table S1). A permutation procedure is proposed
to identify the minimal number of PCs while allowing an effective
correction of the confounding effect. By applying this new
procedure to the two original GWAS with internal controls and
two reconstructed studies with external controls, we documented
its advantage over other commonly used PC selection strategies.
At the expense of computing time, the new procedure is able to
pick fewer PCs while reducing the over-dispersion factor to a
similar or even lower level.
The identified set of 12,898 SNPs with low background LD in
European American population and common to both the Illumina
and Affymetrix commercial platforms can be used in PCA for
evaluation of population structure. We detected similar patterns of
population substructure in the original scans even though they were
nested within different cohorts. The top three axes from the two
independent studies appear to point to similar directions and are
likely to be a characteristic of the European American population.
Further studies are required to correlate differences along the axes
Table 6. Discrepancy in SNP selection for the follow-up study between the permutation procedure and an alternative PC
adjustment strategy.
PC adjustment Strategy PLOCca-PLCOco
a PLCOca-NHSco
b NHSca-NHSco
c NHSca-PLCOco
d
0 PC adjustment
e 7.3% 22.8% 5.6% 22.6%
Adjustment for top 10 PCs
f 4.5% 6.3% 9.4% 6.4%
Adjustment for Significant PCs
g 3.7% 2.6% 8.2% 4.0%
Note: Under the premise that the top 5% of the testing SNPs ranked by the statistic using a given PC adjustment strategy are to be followed-up to the next stage, the
discrepancy the proportion of SNPs selected by this procedure and not selected by the permutation procedure.
aPLCOca-PLCOco is the original PLCO prostate cancer study.
bPLCOca-NHSco is the reconstructed study with prostate cancer cases from the PLCO, and external controls from NHS.
cNHSca-NHSco is the original NHS breast cancer study.
dNHSca-PLCOco is the reconstructed study with breast cancer cases from the NHS, and external controls from PLCO.
eNo PC adjustment in the association test.
fAdjustment for the top 10 PCs ranked by their associated eigenvalues.
gAdjustment for the PCs with significant genetic variation (P-value ,0.05 by the Tracy Widom test).
doi:10.1371/journal.pone.0002551.t006
Table 7. Detection and correction for population stratification using various numbers of SNPs for PCA in the reconstructed study
comparing prostate cancer cases from PLCO with controls from NHS.
Number of SNPs used in
PCA
a
PCs with large genetic
variation
b
PCs associated with
outcome
c
PCs chosen for PS
correction
d
Over-dispersion factor after PS
correction
e
1,500 1
st,2
nd none 1
st 1.067
3,000 1
st,2
nd 1
st,2
nd 1
st,2
nd 1.052
6,000 1
st,2
nd 1
st,2
nd 1
st,2
nd 1.043
9,000 1
st,2
nd,3
rd 1
st,2
nd 1
st,2
nd 1.039
12,898 1
st,2
nd,3
rd,4
th 1
st,2
nd,4
th 1
st,2
nd,4
th 1.032
aSNPs are randomly (except that the large set contains the smaller set) selected from the panel of 12,898 PS inference SNPs that are common to both the Illumina and
Affymetrix commercial platforms.
bThese PCs have a significantly large genetic variation (with P-values less than 0.05 based on the Tracy Wildom test).
cThese PCs have a significantly different distribution between case and control groups (with P-value less than 0.05 based on the Wilcoxon rank-sum test).
dThese PCs were chosen by the proposed permutation procedure for the correction of PS.
eThe over dispersion factor was estimated by applying the 1-df Wald test statistic with the adjustment for the chosen PCs on the set of 241,238 genomic control SNPs.
doi:10.1371/journal.pone.0002551.t007
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background, geographic location or specific demographic histories.
Based on our present experiences, we believe that this set of SNPs
should be sufficient for the inference and correction of population
structure in GWAS conducted using either the Illumina or
Affymetrix commercial platforms within the European American
populations, and enables the comparison of population structure
betweenstudies performed on differentplatformswithoutrelying on
genotype imputation. The same search algorithm can be used to
identify structure inference SNPs suitable for GWAS in other
populations, such as African Americans.
In the replication stages of a multi-stage GWAS, it would be
impractical to genotype the entire list of 12,898 SNPs for the
correction of PS. In the process of selecting a fixed number of
SNPs for the follow-up study that would typically involve 10,000 to
50,000 SNPs, there is always a trade-off between the number of
SNPs allocated for population structure inference and the number
of candidate disease-associated SNPs chosen for the validation/
replication. Recently, Price et al. [32] and Tian et al. [33]
identified panels of SNPs that are informative for discerning major
European ancestries in European American populations. For
example, Price et al. [32] designed a panel of 300 SNPs that aims
to distinguish northwest European, southeast European, and
Ashkenazi Jewish ancestry. These panels of ancestral informative
SNPs are potentially useful in replication studies with a similar
anticipated population substructure, but may not be as robust in
studies where the population sub-structure may be different or
unknown. Rapid accumulation of GWAS and their replication
studies should provide ample opportunities for designing and
validating panels of ancestral informative markers targeting
various stratified or admixed populations.
Our analysis has focused on the confounding effect of PS on
single-marker association analyses. While there is an increasing
emphasis on detecting interactions between genes and between
genes and the environment, Wang et al. [34] recently evaluated
the bias resulting from the confounding effect of PS in studies of
gene-gene or gene-environment interactions. Based on simulation
studies, they showed that bias due to PS could be large for studies
of interactions, especially when strong correlation between genes
(or between genetic and environmental factors) takes place. Using
data generated from the CGEMS project and tools developed in
this paper, we can empirically evaluate the impact of PS on the
study of gene-gene interaction under different control selection
strategies. However, valid assessment of effect of PS on gene-
environment interaction may require additional assumptions
depending on the control selection procedure chosen.
There are several additional issues other than the type I error
inflation arising from PS to consider when evaluating the
appropriateness of convenience controls versus controls selected
to reflect the study-base that produced the cases. There may be
differential genotyping error between cases and controls due to
variation in the processing of biological samples. Also, selection
bias for non-genetic covariates that can not be corrected by PCA
could lead to misleading estimates of interactions [35]. The
selection of cases and controls from a common prospective cohort
tends to minimize potential discrepancies.
The analyses of empirical data generated from the CGEMS
project suggest that the effect of PS in the GWAS of prostate and
breast cancers conducted in European American is small when the
study is epidemiologically well designed, but can be substantial
when controls and cases are drawn from separate studies. The
elevated confounding effect of PS due to the use of less desirable
controls can be effectively mitigated by methods such as the one
proposed here. The impact of using convenience controls on the
power for the detection of disease related markers needs to be
further investigated, especially in recently admixed populations.
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Text S1 An example demonstrating the loss in power due to
unnecessary adjustment of population substructure
Found at: doi:10.1371/journal.pone.0002551.s001 (0.09 MB
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Table S1 Power comparison between the association tests with
and without population substructure adjustment
Found at: doi:10.1371/journal.pone.0002551.s002 (0.03 MB
DOC)
Table S2 List of 12,898 population inference SNPs
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Table S3 Tracy-Widom tests and associated P-values (in
parenthesis) for the significance of principal components based
on 7,017 structure inference SNPs
Found at: doi:10.1371/journal.pone.0002551.s004 (0.03 MB
DOC)
Table S4 Over-dispersion factor (and the empirical type I error
under the significant level of 0.05) when cases and controls are
reassigned so that they are completely separated along a chosen
PC direction.
Found at: doi:10.1371/journal.pone.0002551.s005 (0.03 MB
DOC)
Table S5 Results on the PLCOca-NHSco using the set of
12,536 SNPs on chromosome 20 in the principal components
analysis
Found at: doi:10.1371/journal.pone.0002551.s006 (0.03 MB
DOC)
Figure S1 Distribution of the minor allele frequency of 12,898
population substructure inference SNPs on each autosome. Each
SNP’s physical map position on the chromosome is based on the
reference genome build 36.2 and the latest dbSNP build 128. One
SNP (rs3789771) has no map information and is excluded from the
figure.
Found at: doi:10.1371/journal.pone.0002551.s007 (0.22 MB TIF)
Figure S2 SNP Loadings from PCA using 12,898 population
substructure inference SNPs in the PLCO prostate cancer study.
SNPs are organized according to the order of their chromosome
positions.
Found at: doi:10.1371/journal.pone.0002551.s008 (0.12 MB TIF)
Figure S3 SNP ranking correlation in breast cancer studies. In
each plot, SNPs’ rankings based on the 1 d.f. Wald test on 475,116
testing autosomal SNPs without PC adjustment are compared with
their rankings based on the 1 d.f. Wald test with adjustment for
PCs chosen by the permutation procedure. The SNPs in blue are
ranked among the top 5% by tests both with and without PC
adjustment. The SNPs in green and orange are ranked among the
top 5% by only one of the tests. A) Results based on the original
breast cancer study (breast cancer cases and controls from NHS).
The 2nd PC was chosen for PS correction. B) Results based on the
reconstructed breast cancer study using external controls (breast
cancer cases from NHS, and external controls from PLCO). The
1st, 2nd and 3rd PCs were chosen for PS correction.
Found at: doi:10.1371/journal.pone.0002551.s009 (0.29 MB TIF)
Figure S4 The conditional ranking distribution for the original
NHS breast cancer study. Each plot shows the histogram of ranks
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within a given range by the test with the adjustment for the 2nd
PC (chosen by the proposed permutation procedure). The ranking
ranges (%) are shown on the horizontal axis. The frequencies (%)
are shown on the vertical axis. A) The histogram of ranks for SNPs
ranked in the top 0–1% by the test with PC adjustment. B) The
histogram of ranks for SNPs ranked in the top 1–2% by the test
with PC adjustment. C) The histogram of ranks for SNPs ranked
in the top 2–3% by the test with PC adjustment. D) The histogram
of ranks for SNPs ranked in the top 3–4% by the test with PC
adjustment. E) The histogram of ranks for SNPs ranked in the top
4–5% by the test with PC adjustment.
Found at: doi:10.1371/journal.pone.0002551.s010 (0.02 MB TIF)
Figure S5 The conditional ranking distribution for the recon-
structed breast cancer study using external controls. Each plot
shows the histogram of ranks according to the test without PC
adjustment for SNPs ranked within a given range by the test with
the adjustment for the 1st, 2nd, and 3rd PCs (chosen by the
proposed permutation procedure). The ranking ranges (%) are
shown on the horizontal axis. The frequencies (%) are shown on
the vertical axis. A) The histogram of ranks for SNPs ranked in the
top 0–1% by the test with PC adjustment. B) The histogram of
ranks for SNPs ranked in the top 1–2% by the test with PC
adjustment. C) The histogram of ranks for SNPs ranked in the top
2–3% by the test with PC adjustment. D) The histogram of ranks
for SNPs ranked in the top 3–4% by the test with PC adjustment.
E) The histogram of ranks for SNPs ranked in the top 4–5% by the
test with PC adjustment.
Found at: doi:10.1371/journal.pone.0002551.s011 (0.02 MB TIF)
Figure S6 SNP loadings from PCA using SNPs on chromosome
20 in prostate cancer study using external controls. SNPs are
organized according to their positions (in base pair) on
chromosome 20.
Found at: doi:10.1371/journal.pone.0002551.s012 (0.09 MB TIF)
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